Clearmind Medicine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $8,741,350.

Profit Margin

Clearmind Medicine Inc. (NASDAQ:CMND): Profit margin
2017 0 -6.67K
2018 0 -194.53K
2019 0 -105.28K
2020 0 -233.22K
2021 0 -4.12M
2022 0 -9.41M
2023 0 -11.95M

CMND Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
0000000
Cost of revenue
56.34K113.37K2.57K0000
Gross profit
-56.34K-113.37K-2.57K0000
Operating exp.
Research and development
2.14M2.98M646.48K0000
Selling and marketing
0000000
Total operating expenses
8.74M8.53M3.67M233.22K105.28K254.53K6.67K
Operating income
-8.74M-8.53M-3.45M-233.22K-105.28K-254.53K-6.67K
Other income (expenses), net
-3.18M-837.47K-446.43K-179.68K-360K-1
Income before tax
-11.93M-9.37M-3.89M-233.22K-105.28K-194.53K-6.67K
Income tax expense
24.09K40.75K223.21K-385.98K0-60K0
Net income
-11.95M-9.41M-4.12M-233.22K-105.28K-194.53K-6.67K
Earnings per share
Basic EPS
-59.18-217.17-133.37-12.86-8.54-18.05-0.55
Diluted EPS
-59.04-217.17-133.37-12.86-8.54-18.05-0.55
Data sourceData source